WEL Research Institute
Walloon ExceLlence Research Institute
Supporting strategic basic research of excellence and the translation of disruptive innovations into an impact in health and sustainable transition.
News & Events
News
Publication in Nature
RHOJ : contrôle de la résistance à la chimiothérapie
Cédric Blanpain's team (WEL Research Institute - ULB) discovered that RHOJ allows cancer cells with EMT to resist chemotherapy.
News
Publication in Nature Immunology
Capacité de prolifération inattendue des monocytes sanguins
Thomas Marichal (WEL Research Institute - ULiège) and his team have discovered that blood monocytes, previously considered to be differentiated cells, are in fact capable of proliferating to replace tissue macrophages.
News
Publication in Cell
CnoX: an unexpected partner for GroEL
Jean-François Collet (WEL Research Institute - UCLouvain) and colleagues discovered that the chaperone GroEL works with CnoX, a chaperedoxin that controls the redox quality of GroEL substrates.
Lines of work
Strategic fundamental research
The WEL Research Institute supports strategic basic research through programmes emanating from the universities of the Wallonia-Brussels Federation. Their selection and financial management are carried out via the FRFS, a specialised fund of the FNRS.
Industrial valorisation
The WEL Research Institute provides individualised support for researchers, in partnership with KTO representatives, to integrate the valorisation process into the scientific development of the research programme.
The "Bridge Fund"
The Bridge Fund provides funding for a maturation stage of intellectual property emanating from the WEL Research Institute's programmes to reach the next stage of technology transfer.
Partnerships
The WEL Research Institute has gradually built valorization opportunities that are taking many forms including projects supported by the competitivity clusters, licensing agreements, industry partnerships, and spin-off creation.
No result.
Our partners
